DAWN
Price
$10.73
Change
+$0.14 (+1.32%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.09B
54 days until earnings call
Intraday BUY SELL Signals
FHTX
Price
$6.31
Change
-$0.37 (-5.54%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
377.76M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DAWN vs FHTX

Header iconDAWN vs FHTX Comparison
Open Charts DAWN vs FHTXBanner chart's image
Day One Biopharmaceuticals
Price$10.73
Change+$0.14 (+1.32%)
Volume$30.88K
Capitalization1.09B
Foghorn Therapeutics
Price$6.31
Change-$0.37 (-5.54%)
Volume$2.19K
Capitalization377.76M
DAWN vs FHTX Comparison Chart in %
DAWN
Daily Signal:
Gain/Loss:
FHTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DAWN vs. FHTX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and FHTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (DAWN: $10.59 vs. FHTX: $6.68)
Brand notoriety: DAWN and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 153% vs. FHTX: 174%
Market capitalization -- DAWN: $1.09B vs. FHTX: $377.76M
DAWN [@Biotechnology] is valued at $1.09B. FHTX’s [@Biotechnology] market capitalization is $377.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $115.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 5 TA indicator(s) are bullish while FHTX’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 5 bullish, 4 bearish.
  • FHTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than FHTX.

Price Growth

DAWN (@Biotechnology) experienced а +22.57% price change this week, while FHTX (@Biotechnology) price change was +35.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

DAWN is expected to report earnings on Mar 09, 2026.

FHTX is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DAWN($1.09B) has a higher market cap than FHTX($378M). FHTX YTD gains are higher at: 23.704 vs. DAWN (13.627). FHTX has higher annual earnings (EBITDA): -83.23M vs. DAWN (-162.07M). DAWN has more cash in the bank: 452M vs. FHTX (180M). DAWN has less debt than FHTX: DAWN (2.89M) vs FHTX (22.5M). DAWN has higher revenues than FHTX: DAWN (134M) vs FHTX (24.5M).
DAWNFHTXDAWN / FHTX
Capitalization1.09B378M288%
EBITDA-162.07M-83.23M195%
Gain YTD13.62723.70457%
P/E RatioN/AN/A-
Revenue134M24.5M547%
Total Cash452M180M251%
Total Debt2.89M22.5M13%
TECHNICAL ANALYSIS
Technical Analysis
DAWNFHTX
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signal:
Gain/Loss:
FHTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HBCYF16.230.34
+2.11%
HSBC Holdings Plc
CELJF12.15N/A
N/A
Cellcom Israel, Ltd.
LSMNF19.92N/A
N/A
Lastminute.com NV
SITIY33.22-0.40
-1.18%
SITC International Holdings Company, Ltd.
AUMMF0.03-0.01
-25.77%
AuMEGA Metals Ltd

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-6.53%
BEAM - DAWN
46%
Loosely correlated
+2.55%
VCYT - DAWN
43%
Loosely correlated
-0.92%
FHTX - DAWN
43%
Loosely correlated
+4.70%
XNCR - DAWN
42%
Loosely correlated
-1.62%
REPL - DAWN
42%
Loosely correlated
-0.80%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with IBRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+4.70%
IBRX - FHTX
41%
Loosely correlated
+8.88%
ERAS - FHTX
41%
Loosely correlated
+20.47%
BEAM - FHTX
41%
Loosely correlated
+2.55%
NVAX - FHTX
41%
Loosely correlated
+11.87%
XNCR - FHTX
40%
Loosely correlated
-1.62%
More